Label-free Neutrophil Enrichment from Patient-derived Airway Secretion Using Closed-loop Inertial Microfluidics
June 7th, 2018
5.9K views
In this research, we demonstrate a label-free neutrophil separation method from clinical airway secretions using closed-loop operation of spiral inertial microfluidics. The proposed method would expand the clinical in vitro assays for various respiratory diseases.
Overview
This research presents a label-free method for separating neutrophils from clinical airway secretions using spiral inertial microfluidics. This technique aims to enhance clinical assays for respiratory diseases.
Key Study Components
Area of Science
- Neuroscience
- Microfluidics
- Respiratory Diseases
Background
- Neutrophils play a crucial role in pulmonary diseases.
- Current methods for isolating neutrophils can be chemically invasive.
- Improving neutrophil isolation techniques can aid in disease research.
- This study focuses on a novel, non-invasive method.
Purpose of Study
- To develop a method for isolating neutrophils from airway secretions.
- To enhance the understanding of respiratory diseases.
- To provide a reliable technique for clinical in vitro assays.
Methods Used
- Closed-loop operation of spiral inertial microfluidics.
- Mixing PDMS precursor with a base and curing agent.
- Using a micro machine aluminum mold for PDMS application.
- Demonstration of the procedure by a PhD student.
Main Results
- Successful isolation of neutrophils without chemical disturbance.
- Demonstrated effectiveness in enriching patient samples.
- Potential applications in various pulmonary disease studies.
- Method shows promise for clinical use in respiratory research.
Conclusions
- The label-free method is effective for neutrophil separation.
- This technique can improve research on respiratory diseases.
- Further studies could validate its clinical applications.
Frequently Asked Questions
What are neutrophils?
Neutrophils are a type of white blood cell essential for the immune response, particularly in fighting infections.
How does the spiral inertial microfluidics method work?
This method uses fluid dynamics to separate cells based on their size and density without chemical interference.
What diseases can benefit from this research?
Diseases such as pneumonia, asthma, cystic fibrosis, and chronic obstructive pulmonary disease can benefit from improved neutrophil isolation.
Who conducted the study?
The study was conducted by a research team led by a PhD student named Kyungyong.
What is PDMS?
PDMS, or polydimethylsiloxane, is a silicone-based organic polymer used in microfluidic devices.
Why is a label-free method important?
Label-free methods prevent chemical disturbances that can alter cell behavior, providing more accurate results.
Executive Industry Relevance
Isolating functional neutrophils from heterogeneous airway secretions remains a critical challenge in pulmonary disease research due to mucus viscosity and cellular fragility. This label-free inertial microfluidics approach enables high-yield, chemically undisturbed neutrophil recovery, supporting reliable functional assays for target validation in respiratory inflammation. By preserving neutrophil activity, the method enhances predictive confidence in preclinical models of diseases such as asthma, COPD, and cystic fibrosis.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of neutrophil-mediated pathways in pulmonary inflammation without chemical or physical perturbation.
- Operational Value: Provides a consistent, high-purity neutrophil source for mechanistic de-risking of therapeutic targets.
Screening & Assay Development
- Scientific Value: Delivers quantifiable neutrophil outputs with >94% recovery and functional integrity, as demonstrated by PMA-induced elastase release.
- Operational Value: Supports assay standardization through closed-loop recirculation, ensuring reproducible cell enrichment across variable clinical samples.
Translational & Preclinical Research
- Scientific Value: Maintains neutrophil functionality post-isolation, enabling disease-relevant phenotypic screening and biomarker-linked functional readouts.
- Operational Value: Facilitates translational continuity from patient-derived samples to preclinical evaluation by avoiding ex vivo activation artifacts.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by converting complex airway secretions into a purified neutrophil fraction suitable for downstream functional and omics analyses.
- Discovery Biology: Enables hypothesis testing on neutrophil elastase release and oxidative burst in response to pathophysiological stimuli.
- Screening: Generates standardized neutrophil suspensions for compound screening in neutrophil-driven disease models.
- Analytics: Yields quantitative, functional readouts (e.g., elastase activity) that support dose-response and mechanism-of-action assessments.
- Translational Research: Bridges clinical sample acquisition and preclinical validation by preserving native neutrophil phenotype.
- Enterprise Reuse: The closed-loop microfluidic platform can be adapted to other challenging biofluids (e.g., nasal, intestinal) for immune cell enrichment.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by isolating neutrophils without surface receptor or functional disturbance.
- Operational Value: Achieves high recovery and purity (>94%) across diverse patient samples, minimizing variability in assay outcomes.
- Strategic Value: Improves go/no-go decisions in target validation by providing reliable neutrophil-based functional data.
- Portfolio Impact: Enables risk-adjusted prioritization of pulmonary therapeutics through consistent, clinically relevant immune cell models.
Implementation Considerations
- Requires expertise in microfluidic device fabrication, plasma bonding, and peristaltic pump operation.
- Depends on access to spiral microfluidic chips, vacuum degassing equipment, and temperature-controlled ovens for PDMS curing.
- Necessitates standardized sample dilution (1,000-fold in PBS) and pre-filtration (40 μm strainer) to ensure consistent device performance.
- Adaptation to other biofluids may require recalibration of flow rates and channel dimensions based on viscosity and cell size.
- Practical limitations include the need for aseptic handling and the trade-off between recirculation-enhanced yield and single-run throughput.
Biopharma FAQs
Why does functional neutrophil recovery matter for target validation?
Functional recovery ensures that isolated neutrophils retain native responsiveness to stimuli like PMA, enabling accurate assessment of elastase release and other effector mechanisms critical for validating targets in pulmonary inflammation.
How does isolating variables in microfluidic enrichment support discovery pipeline goals?
By isolating neutrophils from complex mucus without chemical additives, the method eliminates confounding variables, allowing researchers to attribute functional changes directly to experimental conditions rather than isolation artifacts.
What quantitative measurements does neutrophil enrichment enable in respiratory research?
Enrichment enables quantitative functional assays such as PMA-induced elastase release, providing a measurable, dose-responsive readout for evaluating neutrophil activation in disease models and therapeutic screening.
Why are replication requirements important for cross-functional collaboration in neutrophil studies?
Replication across multiple patient samples (as demonstrated in six clinical samples) ensures that enrichment performance is robust and not sample-specific, supporting reliable data sharing between discovery, preclinical, and clinical teams.
What statistical analysis capabilities are needed before implementing this microfluidic method?
Implementation requires the ability to compare recovery rates, purity, and functional output (e.g., elastase levels) across conditions using statistical tests to confirm significant improvements over existing methods like DTT mucolysis.
Chapters in this video
0:04
Title
0:40
Device Fabrication and Soft Lithography
2:19
Tracheal Secretion Collection from Mechanically Ventilated Patients
3:07
Experimental Setup
4:27
Results: Use of Microfluidics to Obtain Label-free Neutrophil from Patient Clinical Airway Secretions
6:04
Conclusion
